Skip to main content

Table 2 General features of the 60 C. difficile genomes employed in this studya

From: Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Strain name (accession no.)

Genome statusa

(no. of contigs)

Total sizea

(Mb)

No. of genesa

G + C contenta(%)

MLST cladeb

STsb

Sampling country

C. difficile CBA7201 (QKRF00000000)c

C (3)

4.34

4,107

28.8

1

17

Korea

C. difficile CBA7202 (QLNX00000000)c

D (3)

4.40

4,204

28.8

1

17

Korea

C. difficile CBA7203 (QKRE00000000)c

D (5)

4.39

4,189

28.8

1

17

Korea

C. difficile CBA7204 (CP029566)c

C (1)

4.04

3,744

28.5

1

203

Korea

C. difficile CBA7205 (QLNY00000000)c

D (7)

4.40

4,176

28.9

1

17

Korea

C. difficile CBA7206 (QLNZ00000000)c

D (7)

4.16

3,911

28.7

1

8

Korea

C. difficile CBA7207 (QLOA00000000)c

D (2)

4.33

4,101

28.8

1

17

Korea

C. difficile CBA7208 (QKRD00000000)c

C (2)

4.08

3,786

28.5

1

4

Korea

C. difficile CBA7209 (QLOB00000000)c

D (2)

4.40

4,191

28.8

1

17

Korea

C. difficile 630 (AM180355-6)

C. difficile DSM 27639 (CP011847)

C. difficile DSM 29745 (CP019857)

C. difficile DSM 29688 (CP019858)

C. difficile W0022a (CP025046)

C. difficile DSM 29632 (CP019860)

C. difficile 08ACD0030 (CP010888)

C. difficile BR81 (CP019870)

C. difficile Mta-79 (CP042267)

C. difficile DSM 28666 (CP012321)

C. difficile DSM 29637 (CP016106)

C. difficile W0023a (CP025045)

C. difficile FDAARGOS_267 (CP020424-6)

C. difficile DH/NAP11/106/ST-42 (CP022524)

C. difficile W0003a (CP025047)

C. difficile 020477 (CP028524)

C. difficile 020709 (CP028529)

C. difficile QCD-63q42 (CM000637)

C. difficile DSM 1296 T (CP011968-9)

C. difficile DSM 27638 (CP011846)

C. difficile DSM 27640 (CP011848)

C. difficile CD-17-01474 (CP026591)

C. difficile R0104a (CP025044)

C. difficile 08-00495 (CP026594)

C. difficile 10-00253 (CP026598)

C. difficile 12-00011 (CP026595)

C. difficile 09-00072 (CP026599)

C. difficile 10-00,078 (CP026597)

C. difficile 10-00071 (CP026596)

C. difficile 12-00008 (CP026593)

C. difficile CD-10-00484 (CP026592)

C. difficile CD196 (FN538970)

C. difficile QCD-66c26 (CM000441)

C. difficile DSM 102860 (CP020379)

C. difficile DSM 102859 (CP020378)

C. difficile VL_0104 (FAAJ00000000)

C. difficile VL_0391 (FALK00000000)

C. difficile ZJCDC-S82 (JYNK00000000)

C. difficile CDT4 (CP029152-3)

C. difficile DSM 29627 (CP016102)

C. difficile DSM 28670 (CP012312)

C. difficile CD161 (CP029154-6)

C. difficile DSM 28669 (CP012323)

C. difficile DSM 29629 (CP016104)

C. difficile M68 (FN668375)

C. difficile DSM 29747 (CP019864)

C. difficile 12038 (CP033214-5)

C. difficile CD10010 (CP033213)

C. difficile M120 (FN665653)

C. difficile CD21062 (CP033216-7)

C. difficile DSM 29,020 (CP012325)

C (2)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (3)

C (1)

C (1)

C (1)

C (1)

D (28)

C (2)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

C (1)

D (15)

C (1)

C (1)

D (261)

D (1,092)

D (20)

C (2)

C (1)

C (1)

C (3)

C (1)

C (1)

C (1)

C (1)

C (2)

C (1)

C (1)

C (2)

C (1)

4.29

4.26

4.24

4.22

4.18

4.17

4.16

4.12

4.12

4.12

4.11

4.11

4.28

4.08

4.07

4.14

4.09

4.44

4.28

4.22

4.22

4.20

4.19

4.17

4.12

4.11

4.11

4.11

4.11

4.11

4.11

4.11

4.12

4.25

4.24

4.06

4.16

4.22

4.28

4.20

4.19

4.47

4.13

4.11

4.3

4.07

4.07

4.04

4.04

4.10

4.13

3981

4026

3975

4041

3942

3891

3907

3813

3844

3829

3844

3804

4049

3743

3765

3873

3792

4213

3984

3966

3964

3939

3924

3902

3,844

3,845

3,842

3,845

3843

3842

3843

3807

3774

4071

4050

3,859

3939

3934

4035

3916

3962

4277

3908

3802

4025

3809

3822

3785

3756

3898

3905

29.0

29.1

29.0

28.9

28.9

28.6

28.8

28.7

28.7

29.0

28.6

28.7

28.7

28.6

28.6

28.8

28.5

28.6

28.7

29.0

29.0

28.9

28.7

28.7

28.6

28.6

28.6

28.6

28.6

28.6

28.6

28.6

28.5

29.0

29.0

28.7

29.0

29.1

28.8

28.8

28.8

28.8

28.8

28.6

28.9

29.1

28.8

28.7

28.7

28.9

29.2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

2

2

2

2

2

2

2

2

2

2

2

2

2

2

3

3

3

3

3

4

4

4

4

4

4

4

5

5

5

5

5

5

54

54

3

15

2

103

2

42

34

48

83

42

3

42

8

110

21

3

3

1

1

1

1

1

1

1

1

1

1

1

1

1

1

5

5

201

201

5

37

37

38

37

109

39

37

11

11

11

11

11

11

Switzerland

Germany

Germany

Germany

USA

Indonesia

Canada

Korea

USA

Ghana

Indonesia

USA

USA

USA

USA

USA

USA

Canada

UK

Germany

Germany

Germany

USA

Germany

Germany

Germany

Germany

Germany

Germany

Germany

Germany

France

Canada

Germany

Germany

Canada

Canada

China

China

Indonesia

Ghana

China

Ghana

Indonesia

Ireland

Germany

China

China

UK

China

Indonesia

  1. aBioinformatic genome analysis was carried out using the NCBI prokaryotic genome annotation pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/)
  2. bMLST clade and ST information was obtained using PubMLST analysis (https://pubmlst.org/cdifficile/)
  3. cGenomes sequenced in this study are highlighted in bold
  4. dGenome status: D draft genome sequence, C complete genome sequence